In the last 12 months, insiders at Rezolute, Inc. ($RZLT) filed 116 transactions with the SEC: 51 open-market purchases totaling $27,456,268 and 0 sales totaling $0. Net insider sentiment: net buying.
Rezolute, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- HANDOK, INC. (Not found) — 2 transactions totaling $17,000,003
- Kim Young-Jin (Not found) — 10 transactions totaling $9,369,857
- Evans Daron (CFO) — 28 transactions totaling $727,425
- ROBERTS BRIAN KENNETH (Chief Medical Officer) — 22 transactions totaling $187,230
- Elam Nevan C (CEO) — 11 transactions totaling $176,857
View all SEC Filings for Rezolute, Inc. (RZLT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Evans Daron | CFO | P | Common Shares | 10000 | $2.85 | 511,462.0000 | 103,687,064 | 1.99% | 0.01% |
| March 2, 2026 | Elam Nevan C | CEO | F | Common Shares | 27618 | $2.99 | 613,501.0000 | 103,687,064 | 4.31% | 0.03% |
| March 2, 2026 | ROBERTS BRIAN KENNETH | Chief Medical Officer | F | Common Shares | 11439 | $2.99 | 312,413.0000 | 103,687,064 | 3.53% | 0.01% |
| March 2, 2026 | Evans Daron | CFO | F | Common Shares | 11438 | $2.99 | 501,462.0000 | 103,687,064 | 2.23% | 0.01% |
| Dec. 16, 2025 | Hogenhuis Wladimir | Not found | P | Common Shares | 5650 | $1.69 | 119,675.0000 | 103,422,647 | 4.96% | 0.01% |
| Dec. 16, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 28000 | $1.70 | 323,852.0000 | 103,422,647 | 9.46% | 0.03% |
| Dec. 15, 2025 | Elam Nevan C | CEO | P | Common Shares | 32000 | $1.59 | 641,119.0000 | 103,422,647 | 5.25% | 0.03% |
| Dec. 15, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | P | Common Shares | 100 | $1.60 | 81,440.0000 | 103,422,647 | 0.12% | 0.00% |
| Dec. 15, 2025 | Evans Daron | CFO | P | Common Shares | 40000 | $1.77 | 512,900.0000 | 103,422,647 | 8.46% | 0.04% |
| Dec. 15, 2025 | Evans Daron | CFO | P | Common Shares | 2500 | $1.79 | 512,900.0000 | 103,422,647 | 0.49% | 0.00% |
| Dec. 15, 2025 | Evans Daron | CFO | P | Common Shares | 2500 | $1.79 | 512,900.0000 | 103,422,647 | 0.49% | 0.00% |
| Dec. 15, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | P | Common Shares | 12000 | $1.62 | 81,340.0000 | 103,422,647 | 17.31% | 0.01% |
| Nov. 19, 2025 | KREHER NERISSA | Not found | A | Director Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 103,422,647 | 9999.99% | 0.01% |
| Nov. 19, 2025 | Evans Daron | CFO | A | Employee Stock Option (Right to Buy) | 63000 | $0.00 | 63,000.0000 | 103,422,647 | 9999.99% | 0.06% |
| Nov. 19, 2025 | Evans Daron | CFO | A | Common Shares | 107000 | $0.00 | 467,900.0000 | 103,422,647 | 29.65% | 0.10% |
| Nov. 19, 2025 | Elam Nevan C | CEO | A | Employee Stock Option (Right to Buy) | 186000 | $0.00 | 186,000.0000 | 103,422,647 | 9999.99% | 0.18% |
| Nov. 19, 2025 | Elam Nevan C | CEO | A | Common Shares | 317000 | $0.00 | 609,119.0000 | 103,422,647 | 108.52% | 0.31% |
| Nov. 19, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | A | Employee Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 103,422,647 | 9999.99% | 0.02% |
| Nov. 19, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | A | Common Shares | 32000 | $0.00 | 69,340.0000 | 103,422,647 | 85.70% | 0.03% |
| Nov. 19, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | A | Common Shares | 123000 | $0.00 | 295,852.0000 | 103,422,647 | 71.16% | 0.12% |
| Nov. 19, 2025 | Labrucherie Gil M | Not found | A | Director Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 103,422,647 | 9999.99% | 0.01% |
| Nov. 19, 2025 | Labrucherie Gil M | Not found | A | Common Shares | 21000 | $0.00 | 109,072.0000 | 103,422,647 | 23.84% | 0.02% |
| Nov. 19, 2025 | FAUCHET PHILIPPE | Not found | A | Director Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 103,422,647 | 9999.99% | 0.01% |
| Nov. 19, 2025 | FAUCHET PHILIPPE | Not found | A | Common Shares | 21000 | $0.00 | 55,500.0000 | 103,422,647 | 60.87% | 0.02% |
| Nov. 19, 2025 | Kim Young-Jin | Not found | A | Director Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 103,422,647 | 9999.99% | 0.01% |
| Nov. 19, 2025 | Kim Young-Jin | Not found | A | Common Shares | 21000 | $0.00 | 8,594,336.0000 | 103,422,647 | 0.24% | 0.02% |
| Nov. 19, 2025 | Harris Erik | Not found | A | Director Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 103,422,647 | 9999.99% | 0.01% |
| Nov. 19, 2025 | Harris Erik | Not found | A | Common Shares | 21000 | $0.00 | 21,000.0000 | 103,422,647 | 9999.99% | 0.02% |
| Nov. 19, 2025 | Hogenhuis Wladimir | Not found | A | Director Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 103,422,647 | 9999.99% | 0.01% |
| Nov. 19, 2025 | Hogenhuis Wladimir | Not found | A | Common Shares | 21000 | $0.00 | 114,025.0000 | 103,422,647 | 22.57% | 0.02% |
| Nov. 19, 2025 | KREHER NERISSA | Not found | A | Common Shares | 21000 | $0.00 | 58,576.0000 | 103,422,647 | 55.89% | 0.02% |
| Aug. 18, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | A | Employee Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 75,999,290 | 9999.99% | 0.36% |
| Aug. 18, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | A | Common Shares | 25000 | $0.00 | 37,340.0000 | 75,999,290 | 202.59% | 0.03% |
| June 25, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 2500 | $4.38 | 174,228.0000 | 70,031,041 | 1.46% | 0.00% |
| June 24, 2025 | Evans Daron | CFO | P | Common Shares | 5000 | $4.05 | 360,900.0000 | 70,031,041 | 1.40% | 0.01% |
| June 13, 2025 | KREHER NERISSA | Not found | P | Common Shares | 3076 | $3.25 | 37,576.0000 | 70,031,041 | 8.92% | 0.00% |
| June 13, 2025 | Kim Young-Jin | Not found | P | Common Shares | 1230769 | $3.25 | 8,573,336.0000 | 70,031,041 | 16.76% | 1.76% |
| June 10, 2025 | KREHER NERISSA | Not found | A | Common Shares | 9000 | $0.00 | 34,500.0000 | 70,031,041 | 35.29% | 0.01% |
| June 10, 2025 | Hogenhuis Wladimir | Not found | A | Common Shares | 9000 | $0.00 | 93,025.0000 | 70,031,041 | 10.71% | 0.01% |
| June 10, 2025 | Hogenhuis Wladimir | Not found | A | Director Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 70,031,041 | 9999.99% | 0.01% |
| June 10, 2025 | Labrucherie Gil M | Not found | A | Director Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 70,031,041 | 9999.99% | 0.01% |
| June 10, 2025 | Labrucherie Gil M | Not found | A | Common Shares | 9000 | $0.00 | 88,072.0000 | 70,031,041 | 11.38% | 0.01% |
| June 10, 2025 | KREHER NERISSA | Not found | A | Director Stock Options (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 70,031,041 | 9999.99% | 0.01% |
| June 10, 2025 | FAUCHET PHILIPPE | Not found | A | Common Shares | 9000 | $0.00 | 34,500.0000 | 70,031,041 | 35.29% | 0.01% |
| June 10, 2025 | Kim Young-Jin | Not found | A | Common Shares | 9000 | $0.00 | 7,342,567.0000 | 70,031,041 | 0.12% | 0.01% |
| June 10, 2025 | Kim Young-Jin | Not found | A | Director Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 70,031,041 | 9999.99% | 0.01% |
| June 10, 2025 | Evans Daron | CFO | A | Common Shares | 26000 | $0.00 | 355,900.0000 | 70,031,041 | 7.88% | 0.04% |
| June 10, 2025 | Evans Daron | CFO | A | Employee Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 70,031,041 | 9999.99% | 0.02% |
| June 10, 2025 | FAUCHET PHILIPPE | Not found | A | Director Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 70,031,041 | 9999.99% | 0.01% |
| June 10, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | A | Common Shares | 26000 | $0.00 | 171,728.0000 | 70,031,041 | 17.84% | 0.04% |
| June 10, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 70,031,041 | 9999.99% | 0.02% |
| June 10, 2025 | Elam Nevan C | CEO | A | Common Shares | 68000 | $0.00 | 292,119.0000 | 70,031,041 | 30.34% | 0.10% |
| June 10, 2025 | Elam Nevan C | CEO | A | Employee Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 70,031,041 | 9999.99% | 0.06% |
| March 31, 2025 | Hogenhuis Wladimir | Not found | P | Common Shares | 6758 | $2.92 | 84,025.0000 | 69,940,319 | 8.75% | 0.01% |
| March 27, 2025 | Elam Nevan C | CEO | P | Common Shares | 12302 | $2.85 | 224,119.0000 | 69,940,319 | 5.81% | 0.02% |
| March 26, 2025 | Evans Daron | CFO | P | Common Shares | 10000 | $2.89 | 329,900.0000 | 69,940,319 | 3.13% | 0.01% |
| March 26, 2025 | Evans Daron | CFO | P | Common Shares | 10000 | $2.88 | 329,900.0000 | 69,940,319 | 3.13% | 0.01% |
| March 25, 2025 | Harris Erik | Not found | A | Director Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 69,940,319 | 9999.99% | 0.09% |
| Feb. 16, 2025 | Labrucherie Gil M | Not found | A | Common Shares | 25500 | $0.00 | 79,072.0000 | 69,940,319 | 47.60% | 0.04% |
| Feb. 16, 2025 | Hogenhuis Wladimir | Not found | A | Common Shares | 25500 | $0.00 | 67,267.0000 | 69,940,319 | 61.05% | 0.04% |
| Feb. 18, 2025 | Hogenhuis Wladimir | Not found | P | Common Shares | 10000 | $4.70 | 77,267.0000 | 69,940,319 | 14.87% | 0.01% |
| Feb. 16, 2025 | Hogenhuis Wladimir | Not found | A | Director Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 69,940,319 | 9999.99% | 0.02% |
| Feb. 16, 2025 | Labrucherie Gil M | Not found | A | Director Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 69,940,319 | 9999.99% | 0.02% |
| Feb. 16, 2025 | KREHER NERISSA | Not found | A | Director Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 69,940,319 | 9999.99% | 0.02% |
| Feb. 16, 2025 | Evans Daron | CFO | A | Common Shares | 77000 | $0.00 | 309,900.0000 | 69,940,319 | 33.06% | 0.11% |
| Feb. 16, 2025 | Evans Daron | CFO | A | Employee Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 69,940,319 | 9999.99% | 0.06% |
| Feb. 16, 2025 | KREHER NERISSA | Not found | A | Common Shares | 25500 | $0.00 | 25,500.0000 | 69,940,319 | 9999.99% | 0.04% |
| Feb. 16, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | A | Common Shares | 77000 | $0.00 | 145,728.0000 | 69,940,319 | 112.04% | 0.11% |
| Feb. 16, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 69,940,319 | 9999.99% | 0.06% |
| Feb. 16, 2025 | Elam Nevan C | CEO | A | Common Shares | 204000 | $0.00 | 211,817.0000 | 69,940,319 | 2609.70% | 0.29% |
| Feb. 16, 2025 | Elam Nevan C | CEO | A | Employee Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 69,940,319 | 9999.99% | 0.17% |
| Feb. 16, 2025 | FAUCHET PHILIPPE | Not found | A | Common Shares | 25500 | $0.00 | 25,500.0000 | 69,940,319 | 9999.99% | 0.04% |
| Feb. 16, 2025 | FAUCHET PHILIPPE | Not found | A | Director Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 69,940,319 | 9999.99% | 0.02% |
| Feb. 16, 2025 | Kim Young-Jin | Not found | A | Common Shares | 25500 | $0.00 | 7,333,567.0000 | 69,940,319 | 0.35% | 0.04% |
| June 25, 2024 | Kim Young-Jin | Not found | P | Common Shares | 1250000 | $4.00 | 7,333,567.0000 | 50,812,332 | 20.55% | 2.46% |
| Feb. 16, 2025 | Kim Young-Jin | Not found | A | Director Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 69,940,319 | 9999.99% | 0.02% |
| Dec. 18, 2024 | Evans Daron | CFO | P | Common Shares | 10000 | $4.29 | 232,900.0000 | 69,736,150 | 4.49% | 0.01% |
| Dec. 12, 2024 | Evans Daron | CFO | P | Common Shares | 9000 | $4.60 | 222,900.0000 | 69,736,150 | 4.21% | 0.01% |
| Dec. 9, 2025 | Evans Daron | CFO | P | Common Shares | 10549 | $5.04 | 213,900.0000 | 103,422,647 | 5.19% | 0.01% |
| Sept. 24, 2024 | Hogenhuis Wladimir | Not found | P | Common Stock | 4259 | $4.70 | 41,767.0000 | 51,466,150 | 11.35% | 0.01% |
| Sept. 23, 2024 | Evans Daron | CFO | A | Employee Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 51,466,150 | 9999.99% | 0.19% |
| June 25, 2024 | Hogenhuis Wladimir | Not found | P | Common Stock | 4815 | $4.15 | 37,508.0000 | 50,812,332 | 14.73% | 0.01% |
| June 14, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 300 | $3.96 | 68,728.0000 | 50,812,332 | 0.44% | 0.00% |
| June 14, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 300 | $3.97 | 68,728.0000 | 50,812,332 | 0.44% | 0.00% |
| June 14, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 3000 | $3.91 | 68,728.0000 | 50,812,332 | 4.56% | 0.01% |
| June 14, 2024 | Evans Daron | CFO | P | Common Shares | 40000 | $4.04 | 203,351.0000 | 50,812,332 | 24.49% | 0.08% |
| June 14, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 4000 | $3.91 | 68,428.0000 | 50,812,332 | 6.21% | 0.01% |
| May 29, 2024 | Evans Daron | CFO | P | Common Shares | 451 | $3.50 | 163,351.0000 | 50,812,332 | 0.28% | 0.00% |
| May 24, 2024 | Evans Daron | CFO | P | Common Shares | 2942 | $3.23 | 162,900.0000 | 50,812,332 | 1.84% | 0.01% |
| May 23, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 1500 | $2.72 | 55,128.0000 | 50,812,332 | 2.80% | 0.00% |
| May 23, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 6000 | $2.68 | 61,128.0000 | 50,812,332 | 10.88% | 0.01% |
| May 23, 2024 | Evans Daron | CFO | P | Common Shares | 58 | $2.85 | 159,958.0000 | 50,812,332 | 0.04% | 0.00% |
| March 28, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 500 | $2.55 | 53,628.0000 | 51,408,000 | 0.94% | 0.00% |
| July 22, 2022 | HANDOK, INC. | Not found | P | Common Shares | 3157895 | $3.80 | 5,942,617.0000 | 19,487,000 | 113.40% | 16.21% |
| Oct. 15, 2021 | HANDOK, INC. | Not found | P | Common Shares | 769231 | $6.50 | 2,784,722.0000 | 8,513,000 | 38.17% | 9.04% |
| March 15, 2024 | Evans Daron | CFO | P | Common Shares | 20000 | $1.69 | 159,900.0000 | 51,408,000 | 14.30% | 0.04% |
| March 14, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 10000 | $1.88 | 53,128.0000 | 51,408,000 | 23.19% | 0.02% |
| March 7, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 500 | $1.85 | 43,128.0000 | 51,408,000 | 1.17% | 0.00% |
| March 7, 2024 | Kim Young-Jin | Not found | P | Common Shares | 36503 | $1.91 | 6,058,067.0000 | 51,408,000 | 0.61% | 0.07% |
| July 22, 2022 | Kim Young-Jin | Not found | P | Common Shares | 78947 | $3.80 | 6,021,564.0000 | 19,487,000 | 1.33% | 0.41% |
| March 7, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 500 | $1.85 | 43,052.0000 | 51,408,000 | 1.18% | 0.00% |
| March 8, 2024 | Evans Daron | CFO | P | Common Shares | 50000 | $1.93 | 139,900.0000 | 51,408,000 | 55.62% | 0.10% |
| Feb. 26, 2024 | Elam Nevan C | CEO | P | Common Shares | 5000 | $1.68 | 7,817.0000 | 51,408,000 | 177.49% | 0.01% |
| Feb. 23, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 6000 | $1.69 | 40,552.0000 | 51,408,000 | 17.37% | 0.01% |
| Feb. 26, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 2000 | $1.70 | 42,552.0000 | 51,408,000 | 4.93% | 0.00% |
| Feb. 16, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | P | Common Shares | 7000 | $1.31 | 34,552.0000 | 51,408,000 | 25.41% | 0.01% |
| Feb. 16, 2024 | Evans Daron | CFO | P | Common Shares | 41900 | $1.30 | 89,900.0000 | 51,408,000 | 87.29% | 0.08% |
| Feb. 16, 2024 | Evans Daron | CFO | P | Common Shares | 4500 | $1.37 | 89,900.0000 | 51,408,000 | 5.27% | 0.01% |
| Feb. 16, 2024 | Evans Daron | CFO | P | Common Shares | 4500 | $1.37 | 89,900.0000 | 51,408,000 | 5.27% | 0.01% |
| Jan. 23, 2024 | KREHER NERISSA | Not found | A | Director Stock Options (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 51,408,000 | 9999.99% | 0.06% |
| Jan. 23, 2024 | FAUCHET PHILIPPE | Not found | A | Director Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 51,408,000 | 9999.99% | 0.06% |
| Jan. 23, 2024 | Evans Daron | CFO | A | Employee Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 51,408,000 | 9999.99% | 0.53% |
| Jan. 23, 2024 | ROBERTS BRIAN KENNETH | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 51,408,000 | 9999.99% | 0.25% |
| Jan. 23, 2024 | Elam Nevan C | CEO | A | Employee Stock Options (Right to Buy) | 340000 | $0.00 | 340,000.0000 | 51,408,000 | 9999.99% | 0.66% |
| Jan. 23, 2024 | Hogenhuis Wladimir | Not found | A | Director Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 51,408,000 | 9999.99% | 0.06% |
| Jan. 23, 2024 | Labrucherie Gil M | Not found | A | Director Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 51,408,000 | 9999.99% | 0.06% |